Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release

Bacteria-driven biohybrid microbots have shown great potential in cancer treatment. However, how precisely controlling drug release at the tumor site is still an issue. To overcome the limitation of this system, we proposed the ultrasound-responsive SonoBacteriaBot (DOX-PFP-PLGA@EcM). Doxorubicin (D...

Full description

Bibliographic Details
Main Authors: Meng Du, Ting Wang, Renjie Feng, Penghui Zeng, Zhiyi Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1144963/full
_version_ 1797895422674468864
author Meng Du
Meng Du
Ting Wang
Ting Wang
Renjie Feng
Renjie Feng
Penghui Zeng
Penghui Zeng
Zhiyi Chen
Zhiyi Chen
Zhiyi Chen
author_facet Meng Du
Meng Du
Ting Wang
Ting Wang
Renjie Feng
Renjie Feng
Penghui Zeng
Penghui Zeng
Zhiyi Chen
Zhiyi Chen
Zhiyi Chen
author_sort Meng Du
collection DOAJ
description Bacteria-driven biohybrid microbots have shown great potential in cancer treatment. However, how precisely controlling drug release at the tumor site is still an issue. To overcome the limitation of this system, we proposed the ultrasound-responsive SonoBacteriaBot (DOX-PFP-PLGA@EcM). Doxorubicin (DOX) and perfluoro-n-pentane (PFP) were encapsulated in polylactic acid-glycolic acid (PLGA) to form ultrasound-responsive DOX-PFP-PLGA nanodroplets. Then, DOX-PFP-PLGA@EcM is created by DOX-PFP-PLGA amide-bonded to the surface of E. coli MG1655 (EcM). The DOX-PFP-PLGA@EcM was proved to have the characteristics of high tumor-targeting efficiency, controlled drug release capability, and ultrasound imaging. Based on the acoustic phase change function of nanodroplets, DOX-PFP-PLGA@EcM enhance the signal of US imaging after ultrasound irradiation. Meanwhile, the DOX loaded into DOX-PFP-PLGA@EcM can be released. After being intravenously injected, DOX-PFP-PLGA@EcM can efficiently accumulate in tumors without causing harm to critical organs. In conclusion, the SonoBacteriaBot has significant benefits in real-time monitoring and controlled drug release, which has significant potential applications for therapeutic drug delivery in clinical settings.
first_indexed 2024-04-10T07:25:23Z
format Article
id doaj.art-a9010a8aa4e5425c803b4aa88129d0b3
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-10T07:25:23Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-a9010a8aa4e5425c803b4aa88129d0b32023-02-24T07:40:34ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-02-011110.3389/fbioe.2023.11449631144963Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled releaseMeng Du0Meng Du1Ting Wang2Ting Wang3Renjie Feng4Renjie Feng5Penghui Zeng6Penghui Zeng7Zhiyi Chen8Zhiyi Chen9Zhiyi Chen10The First Affiliated Hospital, Medical Imaging Centre, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaInstitute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, ChinaThe First Affiliated Hospital, Medical Imaging Centre, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaInstitute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, ChinaInstitute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, ChinaThe Seventh Affiliated Hospital, Hunan Veterans Administration Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, ChinaThe First Affiliated Hospital, Medical Imaging Centre, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaInstitute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, ChinaThe First Affiliated Hospital, Medical Imaging Centre, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaInstitute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, ChinaThe Seventh Affiliated Hospital, Hunan Veterans Administration Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, ChinaBacteria-driven biohybrid microbots have shown great potential in cancer treatment. However, how precisely controlling drug release at the tumor site is still an issue. To overcome the limitation of this system, we proposed the ultrasound-responsive SonoBacteriaBot (DOX-PFP-PLGA@EcM). Doxorubicin (DOX) and perfluoro-n-pentane (PFP) were encapsulated in polylactic acid-glycolic acid (PLGA) to form ultrasound-responsive DOX-PFP-PLGA nanodroplets. Then, DOX-PFP-PLGA@EcM is created by DOX-PFP-PLGA amide-bonded to the surface of E. coli MG1655 (EcM). The DOX-PFP-PLGA@EcM was proved to have the characteristics of high tumor-targeting efficiency, controlled drug release capability, and ultrasound imaging. Based on the acoustic phase change function of nanodroplets, DOX-PFP-PLGA@EcM enhance the signal of US imaging after ultrasound irradiation. Meanwhile, the DOX loaded into DOX-PFP-PLGA@EcM can be released. After being intravenously injected, DOX-PFP-PLGA@EcM can efficiently accumulate in tumors without causing harm to critical organs. In conclusion, the SonoBacteriaBot has significant benefits in real-time monitoring and controlled drug release, which has significant potential applications for therapeutic drug delivery in clinical settings.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1144963/fullultrasounddrug deliverycontrolled releasebiohybrid microbotsbacteria
spellingShingle Meng Du
Meng Du
Ting Wang
Ting Wang
Renjie Feng
Renjie Feng
Penghui Zeng
Penghui Zeng
Zhiyi Chen
Zhiyi Chen
Zhiyi Chen
Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
Frontiers in Bioengineering and Biotechnology
ultrasound
drug delivery
controlled release
biohybrid microbots
bacteria
title Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
title_full Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
title_fullStr Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
title_full_unstemmed Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
title_short Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release
title_sort establishment of ultrasound responsive sonobacteriabot for targeted drug delivery and controlled release
topic ultrasound
drug delivery
controlled release
biohybrid microbots
bacteria
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1144963/full
work_keys_str_mv AT mengdu establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT mengdu establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT tingwang establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT tingwang establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT renjiefeng establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT renjiefeng establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT penghuizeng establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT penghuizeng establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT zhiyichen establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT zhiyichen establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease
AT zhiyichen establishmentofultrasoundresponsivesonobacteriabotfortargeteddrugdeliveryandcontrolledrelease